Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5631301

NS(=O)(=O)c1ccc(CNCc2nonc2/C(=N/O)Nc2ccc(F)c(Cl)c2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
CA2 P00918 9/20 0.47
CA1 P00915 8/20 0.43
CA9 Q16790 7/20 0.43
CA7 P43166 4/20 0.43
SOS1 Q07889 1/20 0.41
MAPT P10636 5/20 0.40
ALDH1A1 P00352 2/20 0.40
HTT P42858 1/20 0.40
CA12 O43570 2/20 0.38
MAP3K8 P41279 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
IDO1 P14902 1/20 0.37
RORC P51449 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5631311 1.00 MEN1 (0.50) MEN1KMT2ACA2CA1CA9
SCHEMBL5632261 0.95 MEN1 (0.55) MEN1KMT2ACA2CA1CA9
SCHEMBL5632268 0.95 MEN1 (0.55) MEN1KMT2ACA2CA1CA9
Trifluoroacetic Acid SCHEMBL5629977 0.93 CA2 (0.47) MEN1KMT2ACA2CA1CA9
Trifluoroacetic Acid SCHEMBL5629964 0.93 CA2 (0.47) MEN1KMT2ACA2CA1CA9
SCHEMBL5631303 0.88 MEN1 (0.49) MEN1KMT2ACA2CA1CA9
SCHEMBL5633130 0.88 MEN1 (0.50) MEN1KMT2ACA2CA1CA9
SCHEMBL5633126 0.88 MEN1 (0.50) MEN1KMT2ACA2CA1CA9
Trifluoroacetic Acid SCHEMBL5630908 0.86 IDO1 (0.44) MEN1KMT2ACA2SMN1; SMN2IDO1
Trifluoroacetic Acid SCHEMBL5630916 0.86 IDO1 (0.44) MEN1KMT2ACA2SMN1; SMN2IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase INCYTE CORPORATION 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185165-A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase IDO1, IDO2, HNMT MEN1 1163/4885KMT2A 545/4885CA2 2163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.